Cargando…

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

SARS-CoV-2-specific memory T cells will likely prove critical for long-term immune protection against COVID-19. Here, we systematically mapped the functional and phenotypic landscape of SARS-CoV-2-specific T cell responses in unexposed individuals, exposed family members, and individuals with acute...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sekine, Takuya, Perez-Potti, André, Rivera-Ballesteros, Olga, Strålin, Kristoffer, Gorin, Jean-Baptiste, Olsson, Annika, Llewellyn-Lacey, Sian, Kamal, Habiba, Bogdanovic, Gordana, Muschiol, Sandra, Wullimann, David J., Kammann, Tobias, Emgård, Johanna, Parrot, Tiphaine, Folkesson, Elin, Rooyackers, Olav, Eriksson, Lars I., Henter, Jan-Inge, Sönnerborg, Anders, Allander, Tobias, Albert, Jan, Nielsen, Morten, Klingström, Jonas, Gredmark-Russ, Sara, Björkström, Niklas K., Sandberg, Johan K., Price, David A., Ljunggren, Hans-Gustaf, Aleman, Soo, Buggert, Marcus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427556/ https://www.ncbi.nlm.nih.gov/pubmed/32979941 http://dx.doi.org/10.1016/j.cell.2020.08.017

Ejemplares similares

MAIT cell activation and dynamics associated with COVID-19 disease severity
por: Parrot, Tiphaine, et al.
Publicado: (2020)

Innate lymphoid cell composition associates with COVID‐19 disease severity
por: García, Marina, et al.
Publicado: (2020)

SARS‐CoV‐2‐specific humoral and cellular immunity persists through 9 months irrespective of COVID‐19 severity at hospitalisation
por: Sandberg, John Tyler, et al.
Publicado: (2021)

High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19
por: Lourda, Magda, et al.
Publicado: (2021)

COVID‐19‐specific metabolic imprint yields insights into multiorgan system perturbations
por: Cornillet, Martin, et al.
Publicado: (2021)

Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity
por: Kvedaraite, Egle, et al.
Publicado: (2021)

MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccine
por: Boulouis, Caroline, et al.
Publicado: (2022)

Factors Influencing Functional Heterogeneity in Human Mucosa-Associated Invariant T Cells
por: Dias, Joana, et al.
Publicado: (2018)

Safety and immunogenicity following co-administration of Yellow fever vaccine with Tick-borne encephalitis or Japanese encephalitis vaccines: Results from an open label, non-randomized clinical trial
por: Sandberg, John Tyler, et al.
Publicado: (2023)

Cell-Mediated Immune Responses and Immunopathogenesis of Human Tick-Borne Encephalitis Virus-Infection
por: Blom, Kim, et al.
Publicado: (2018)

NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals
por: Cuapio, Angelica, et al.
Publicado: (2022)

Targeted plasma proteomics reveals signatures discriminating COVID-19 from sepsis with pneumonia
por: Palma Medina, Laura M., et al.
Publicado: (2023)

Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination
por: Gao, Yu, et al.
Publicado: (2022)

The Karolinska KI/K COVID‐19 immune atlas: An open resource for immunological research and educational purposes
por: Ljunggren, Hans‐Gustaf, et al.
Publicado: (2022)

Natural killer cell immunotypes related to COVID-19 disease severity
por: Maucourant, Christopher, et al.
Publicado: (2020)

Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination
por: Blixt, Lisa, et al.
Publicado: (2022)

Local and Systemic Immunity During Five Vaccinations Against SARS-CoV-2 in Zanubrutinib-Treated Patients With Chronic Lymphocytic Leukemia
por: Andersson, Maria, et al.
Publicado: (2023)

NK Cell Activation in Human Hantavirus Infection Explained by Virus-Induced IL-15/IL15Rα Expression
por: Braun, Monika, et al.
Publicado: (2014)

Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXID
por: Chen, Puran, et al.
Publicado: (2023)

Hantavirus-infection Confers Resistance to Cytotoxic Lymphocyte-Mediated Apoptosis
por: Gupta, Shawon, et al.
Publicado: (2013)

Natural killer cells in antiviral immunity
por: Björkström, Niklas K., et al.
Publicado: (2021)

Specificity and Dynamics of Effector and Memory CD8 T Cell Responses in Human Tick-Borne Encephalitis Virus Infection
por: Blom, Kim, et al.
Publicado: (2015)

Elevated CD21(low) B Cell Frequency Is a Marker of Poor Immunity to Pfizer-BioNTech BNT162b2 mRNA Vaccine Against SARS-CoV-2 in Patients with Common Variable Immunodeficiency
por: Bergman, Peter, et al.
Publicado: (2022)

Deaths from Tick-Borne Encephalitis, Sweden
por: Varnaitė, Renata, et al.
Publicado: (2022)

MAIT cell activation is associated with disease severity markers in acute hantavirus infection
por: Maleki, Kimia T., et al.
Publicado: (2021)

Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus
por: Björkström, Niklas K., et al.
Publicado: (2011)

Neutralizing SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Give Patients with X-Linked Agammaglobulinemia Limited Passive Immunity to the Omicron Variant
por: Lindahl, Hannes, et al.
Publicado: (2022)

Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial
por: Bergman, Peter, et al.
Publicado: (2021)

Orthohantaviruses belonging to three phylogroups all inhibit apoptosis in infected target cells
por: Solà-Riera, Carles, et al.
Publicado: (2019)

Hantavirus inhibits apoptosis by preventing mitochondrial membrane potential loss through up-regulation of the pro-survival factor BCL-2
por: Solà-Riera, Carles, et al.
Publicado: (2020)

Comparison of Lung-Homing Receptor Expression and Activation Profiles on NK Cell and T Cell Subsets in COVID-19 and Influenza
por: Brownlie, Demi, et al.
Publicado: (2022)

T-cell immune responses following vaccination with mRNA BNT162b2 against SARS-CoV-2 in patients with chronic lymphocytic leukemia: results from a prospective open-label clinical trial
por: Blixt, Lisa, et al.
Publicado: (2022)

Persistence of salivary antibody responses after COVID-19 vaccination is associated with oral microbiome variation in both healthy and people living with HIV
por: Ghorbani, Mahin, et al.
Publicado: (2023)

Characterization of Natural Killer Cell Phenotype and Function during Recurrent Human HSV-2 Infection
por: Björkström, Niklas K., et al.
Publicado: (2011)

Innate and adaptive immune responses against human Puumala virus infection: immunopathogenesis and suggestions for novel treatment strategies for severe hantavirus‐associated syndromes
por: Klingström, J., et al.
Publicado: (2019)

Cytomegalovirus-Driven Adaptive-Like Natural Killer Cell Expansions Are Unaffected by Concurrent Chronic Hepatitis Virus Infections
por: Malone, David F. G., et al.
Publicado: (2017)

Perturbed CD8(+) T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals
por: Tauriainen, Johanna, et al.
Publicado: (2017)

Functional SARS-CoV-2 cross-reactive CD4(+) T cells established in early childhood decline with age
por: Humbert, Marion, et al.
Publicado: (2023)

Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversity
por: Strunz, Benedikt, et al.
Publicado: (2018)

SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Show Markedly Reduced Cross-reactivities Against Omicron Variants
por: Lindahl, Hannes, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uh8p60g2sbo9qg5i7rml2mf7p4